Intermediate Capital Group

Intermediate Capital Group plc, established in 1989, is a global investment firm specializing in private debt, credit, and equity investments. It focuses on middle-market companies, providing financing solutions across the capital structure, including growth capital, acquisition finance, and real estate debt. The firm invests in various sectors, with a preference for insurance, healthcare, education, and commercial real estate in the United Kingdom. It operates in North America, Europe, and Asia Pacific, with offices across these regions. Intermediate Capital Group manages assets from third-party investors and its balance sheet, totaling €12.1 billion. It is one of the largest independent mezzanine providers globally, known for its long track record in European senior loans and high yield bonds. The firm structures its investments as subordinated loans with equity warrants, preferred equity, and other debt instruments, typically with maturities of seven to ten years. It seeks minority and majority stakes in companies and aims to build genuine partnerships with management teams.

Simon Ainley

Managing Director

Jaynika Amin

Associate

Miro Angelov

Associate Director, European Fund VIII

Daniel Aymerich Llombart

Head of Iberia, Equity and Mezzanine

Paul Barry

Managing Director

Luigi Bartone

Managing Director

Julia Beinker

Managing Director

Fiona Bell

Principal

Tom Bennett

Managing Director

Adi Bhagwat

Managing Director, Strategic Equity

David Bicarregui

CFO and Board Member

Steffen Boehmert

Managing Director

Pascal Borello

Managing Director

Chad Brown

Managing Director

Christophe Browne

Managing Director, Strategic Equity

Pablo Burgos

Managing Director, Direct Lending

Laurent Catry

Managing Director, Mid-Market

Jaime Chocron

Managing Director and Head of Iberia, Equity and Mezzanine

Connelly, Christopher James

Senior Managing Director and Head of Operations and IT

Devarshi Das

Managing Director and Head of Asia-Pacific Infrastructure Equity

Isabelle Demir

Managing Director, Infrastructure

Pénélope Dietsch

Managing Director

Louise Dooly

Managing Director

Benoit Durteste

Chief Investment Officer and CEO

Evan Eason

Managing Director

Stelios Elia

Managing Director

René Faber

Managing Director

Robert Faulkner

Managing Director

Matt Field

Managing Director

James Giannas

Managing Director

Olivier Golder

Managing Director

Adam Goodman

Managing Director

Tobias Haeusel

Managing Director

Adam Hayner

Managing Director

Frank Heiss

Managing Director

Tor Holberg Herno

Managing Director

Anthony Heyman

Managing Director

Alexandra Hone

Managing Director

Richard Howgego

Managing Director

Alan Jones

Senior Managing Director

Wooseok Jun

Managing Director

Ludovic Laforge

Managing Director - Infrastructure and Assistant Director

Luca Lelli

Managing Director

Ryan Levitt

Managing Director

Daisy Liu

Managing Director, Greater China

Ricardo Lombardi

Head of Europe and Asia, Strategic Equity

Steve Machin

Managing Director

Matthew Main

Managing Director

David Malton

Principal

Allan P. Marchington

Managing Director, Head of Life Sciences

Aisling McCarthy

Managing Director

Justin McDougall

Principal

Julian Naylor

Managing Director

Esther Nayyar

Managing Director

Will OConnell

Principal

Eimear Palmer

Managing Director, Head of Responsible Investing

Michael Park

Managing Director, Strategic Equity

Mark Piasecki

Managing Director

Giulio Piccinini

Managing Director and Head of Italy

Jesper Poulsen

Managing Director

Zhengwei Qian

Senior Managing Director

Jeffrey Rabel

Managing Director

Jamie Rivers

Managing Director

Rafael Rizo-Patron

Managing Director

Matthew Robinson

Managing Director

Alan Ross

Managing Director, Special Situations Investments

Wouter Rovekamp

Associate Director

Sfeir, Thomas

Associate Director, Direct Lending

Jérôme Sousselier

Managing Director, Infrastructure

Brian Spenner

Managing Director

Michael Sproul

Managing Director

Jun Suzuki

Managing Director and Head of Japan, Equity and Mezzanine

Toby Sykes

Managing Director, Life Sciences

Lei Tao

Chief Investment Officer and Managing Director

Luca Torchio

Managing Director

Ottavia Tuinhout

Investment Manager

Matthieu Vigier

Co-Head of Senior Debt Partners, Corporate strategies, Managing Director and Portfolio Manager

Hector Wang

Principal

Tracy Weightman

Associate Director, Life Sciences

Thomas Von Werner Ph.D

Managing Director

Malcolm White

Managing Director, Institutional Business and Head of UK LGPS

Kirsten Winterhager

Managing Director

Roger Zhong

Principal

Guillaume d'Engremont

Head of European Infrastructure Equity and Managing Director

Allan Marchington Ph.D

Managing Director and Head of Life Sciences

Toby Sykes Ph.D

Managing Director, Life Sciences

Past deals in Series H

F2G

Series H in 2024
F2G Ltd is a biotechnology company based in Manchester, United Kingdom, that specializes in developing innovative therapies for serious fungal diseases. Established in 1998, F2G focuses on its F3 series of antifungal compounds, particularly targeting challenging fungi such as Aspergillus and other filamentous molds that pose significant health risks. The company leverages its proprietary genomics technology, MycoBank, to identify critical gene targets in fungi, facilitating the creation of effective antifungal agents. Since its initial funding in 2002, F2G has expanded its research and development capabilities, enabling it to advance its patented compounds and contribute to addressing life-threatening fungal infections that affect individuals with compromised immune systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.